Search by Drug Name or NDC

    NDC 71610-0405-80 VERAPAMIL HYDROCHLORIDE 180 mg/1 Details

    VERAPAMIL HYDROCHLORIDE 180 mg/1

    VERAPAMIL HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is VERAPAMIL HYDROCHLORIDE.

    Product Information

    NDC 71610-0405
    Product ID 71610-405_335e56e6-a09f-488d-84dc-06f0b50950df
    Associated GPIs 34000030100415
    GCN Sequence Number 013670
    GCN Sequence Number Description verapamil HCl TABLET ER 180 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 32471
    HICL Sequence Number 000180
    HICL Sequence Number Description VERAPAMIL HCL
    Brand/Generic Generic
    Proprietary Name VERAPAMIL HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name VERAPAMIL HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 180
    Active Ingredient Units mg/1
    Substance Name VERAPAMIL HYDROCHLORIDE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206173
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0405-80 (71610040580)

    NDC Package Code 71610-405-80
    Billing NDC 71610040580
    Package 180 TABLET in 1 BOTTLE (71610-405-80)
    Marketing Start Date 2020-03-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 2712ab16-122b-4f44-a687-e2cb3c04019e Details

    Revised: 4/2020